Geode Capital Management, LLC Monopar Therapeutics Transaction History
Geode Capital Management, LLC
- $1.12 Trillion
- Q2 2024
A detailed history of Geode Capital Management, LLC transactions in Monopar Therapeutics stock. As of the latest transaction made, Geode Capital Management, LLC holds 60,036 shares of MNPR stock, worth $926,355. This represents 0.0% of its overall portfolio holdings.
Number of Shares
60,036
Previous 41,199
45.72%
Holding current value
$926,355
Previous $28,000
53.57%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding MNPR
# of Institutions
10Shares Held
379KCall Options Held
0Put Options Held
0-
Israel Englander Millennium Management LLC | New York, Ny194KShares$3 Million0.0% of portfolio
-
Two Sigma Securities, LLC New York, NY47.1KShares$726,1040.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA45.2KShares$696,9260.0% of portfolio
-
Virtu Financial LLC New York, NY18.8KShares$290,7010.0% of portfolio
-
Tower Research Capital LLC (Trc) New York, NY7.92KShares$122,2360.0% of portfolio
About Monopar Therapeutics
- Ticker MNPR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 12,725,800
- Market Cap $196M
- Description
- Monopar Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics for the treatment of cancer in the United States. Its lead product candidate in development is Validive, a clonidine hydrochloride mucobuccal tablet that is in Phase 2b/3 clinical trial for the prevention of chemoradiotherapy induced severe ...